LEXINOR AS
Operating
Investering/kjøp/salg av eiendom, laboratorier og biologiske
tjenester, medisinsk og kosmetiske tjenester.
Konsulenttjenester innen medisinsk laboratoriet
Organization
- CEO
- KP
Kambiz Persley1969
- Chairman of the board
- KP
Kambiz Persley1969
- Years since formation
- 7 years
- since Dec 5, 2019
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 10,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 2,920,985
- NOK
- Annual total result 2025
- 419,067
- NOK
- Total equity 2025
- 2,634,112
- NOK
Last update: Apr 20, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
KP 1969 | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
KP 1969 | Chairman | 100 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
KP 1969 | Managing Director/CEO, Chairman | 100 % directly |
Last update: Dec 31, 2024
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
KP 1969 | Ordinary shares | 10,000 | 100 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 2,920,985 | 6,388,510 | 2,998,095 | 6,696,614 | 0 |
Annual Total Result | 419,067 | 2,193,740 | 273,428 | 407,780 | -6,630 |
Total assets | 3,574,767 | 4,704,953 | 2,141,930 | 541,953 | 19,848 |
Total liabilities | 940,655 | 2,489,908 | 1,444,625 | 118,076 | 3,750 |
Total equity | 2,634,112 | 2,215,045 | 697,305 | 423,878 | 16,098 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 2,920,985 | 6,388,510 | 2,998,095 | 6,696,614 | 0 |
Total operating costs | 2,337,399 | 3,566,534 | 2,646,786 | 6,173,819 | 7,443 |
Operating result | 583,586 | 2,821,976 | 351,309 | 522,795 | -7,443 |
Financial income/costs | -45,644 | -9,697 | -2 | 0 | 0 |
Profit before tax | 537,941 | 2,812,280 | 351,307 | 522,795 | -7,443 |
Total tax & extraordinary income/cost | 118,874 | 618,540 | 77,879 | 115,015 | -813 |
Annual Total Result | 419,067 | 2,193,740 | 273,428 | 407,780 | -6,630 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 493,880 | 605,405 | 10,328 | 10,328 | 13,191 |
Total current assets | 3,080,888 | 4,099,548 | 2,131,602 | 531,625 | 6,657 |
Total assets | 3,574,767 | 4,704,953 | 2,141,930 | 541,953 | 19,848 |
Short term debt | 460,334 | 1,898,517 | 1,444,625 | 118,076 | 3,750 |
Long term debt | 480,321 | 591,391 | 0 | 0 | 0 |
Total liabilities | 940,655 | 2,489,908 | 1,444,625 | 118,076 | 3,750 |
Contributed capital | 30,000 | 20,680 | 20,680 | 20,680 | 20,680 |
Retained earnings | 2,604,112 | 2,194,365 | 676,625 | 403,198 | -4,582 |
Total equity | 2,634,112 | 2,215,045 | 697,305 | 423,878 | 16,098 |
Total equity and liabilities | 3,574,767 | 4,704,953 | 2,141,930 | 541,953 | 19,848 |
Classification
21st company classification
BETA
Scaleup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises